Corporates

CAPITAL RAISING SERVICES

At Canary Capital, we are passionate about supporting Startups, Early Stage and Emerging Companies.

Benefit from partnering with us to raise working and growth capital through our extensive investor and broker networks. Depending on the stage of your business, raise capital via Angel, Venture (VC), Seed, Mezzanine, Debt, IPO, RTO, Private Placements and other funding options.

Pre-IPO Capital Raising

Our Pre-IPO capital raising aims to bring in savvy high net worth and strategic investors who share your vision. These sophisticated investors may also add value through their own networks and experience.

Initial Public Offering (IPO)

We have a wealth of experience floating unlisted companies by offering shares to the public for the first time. We strategically advise you through the IPO process and help you manage the aftermarket.

Reverse Take Overs (RTO)

An RTO may be a simpler and less costly option to raise growth capital compared to an IPO. Reverse takeovers may also offer other strategic benefits that Canary Capital can advise you on.

Secondary Capital Raising

Raise further expansion capital through private placements or rights issues with our private investors. We can also find buyers for investors who wish to sell down equity stakes in their investments.

BOUTIQUE CORPORATE ADVISORY SERVICES

Our Corporate Advisory services aim to help you build a long term, successful and sustainable business.

Strategic Advice

Unlock the maximum value of your business our with strategic advice and analysis, capital structuring and shareholder management.

Investor Marketing

Gain maximum impact and save time by letting Canary Capital help you with your ASX announcements, investor presentations, road shows and media announcements.

M&A Advisory

Gain greater growth prospects, diversification, customers and other assets through mergers and acquisitions of other businesses.

Board Members

We help secure and grow your business further by sourcing new board members with fresh ideas, experience and networks.

RECENT CAPITAL RAISING SUCCESS

Exosome Medicine Company

2020 & 2021

A$22,200,000

Corporate Advisor & Lead Manager

Innovative biotechnology leader developing transformative new drugs

2021

A$11,000,000

Joint Lead Manager

Transforming Nerve Repair

2020 & 2021

A$3,600,000

Lead Manager

World Class Technology

2018, 2019 & 2020

A$19,300,000

Corporate Advisor, Lead Manager, Joint Lead Manager & Sub-underwriter

Secure Collaboration

2018, 2019,2020, 2021 & 2022

A$6,700,000

Lead Manager

Combining Multiple AI Technologies on one Platform

2022

A$2,500,000

Lead Manager

Australian Based Resource Company

2021

A$600,000

Lead Manager

3D Data Solved

2018 & 2019

A$3,650,000

Corporate Advisor & Lead Manager

Security Made Simple

2019 & 2020

$1,200,000

Lead Manager

Enterprise ESG Outcomes

2018, 2019, 2020

A$4,605,000

Corporate Advisor, Lead Manager & Sub-underwriter

Smart Digital Payments

2018, 2019 & 2020

A$4,858,500

Corporate Advisor, Lead Manager & Joint Lead Manager

Managed Cyber Security

2018, 2019 & 2020

A$8,000,000

Corporate Advisor & Lead Manager

WHAT OUR CLIENTS SAY

Canary Capital is a vital and trusted partner for Nyrada (ASX:NYR) and they share our vision for advancing healthcare. The team at Canary Capital demonstrates a thorough approach to understanding, assessing, and selecting partners, and we have been impressed by the level of service and support they offer our business, as well as by how much they value their clients. The Canary team is always looking for ways in which they can assist Nyrada in promoting the company to investors and raising knowledge and understanding of our drug development programs.

James BonnarCEO, Nyrada Inc

Canary Capital has worked with Exopharm (ASX:EX1) over the past 2 years – and particularly over the past 12 months. Over that time, Canary Capital has provided us a range of services and outcomes, all at the highest professional standard. My experience with Canary Capital has been very positive and they have demonstrated capabilities that match their promises time after time. As Exopharm evolves and grows, Canary Capital continues to provide important support and advice that we can rely upon and trust.

Ian DixonFounder and MD, Exopharm Limited

When raising money to grow your company it is critical to have a partner that understands your vision and that all money is not equal. Working with Paul and Arun from the Canary team to raise funds and accelerate our growth has been a fundamental part of our success at DekkoSecure

Jacqui NelsonCEO, DekkoSecure

From the beginning, Canary Capital has been avid supporters of our vision and our management team. As a start-up, there were a number of hurdles we had to overcome in our first year and it has been humbling to have the unerring support of Canary every step of the way. They have maintained ongoing communications with us, offering sound advice and professional expertise when we need it. In particular, Paul and Arun’s positive endorsement with investors has been important to the success of our business thus far.

Paul GuilfoyleMD, Harvest Technology Group

K2fly has been involved with Canary Capital since 2017 and is delighted to recommend them as a trusted partner. On a personal level, I have benefitted greatly from their support, advice, and guidance in the last 4 years. They have helped establish K2fly as a significant Australian IT company on the ASX and they have worked tirelessly to promote the company to a wide range of investors.

Brian MillerCEO K2fly Limited

GET INVESTMENT OPPORTUNITIES OR
RAISE CAPITAL

Contact Us